Showing results (101-110 of 114) with videos related to
Sort By:
Pageof 12
EMBO Molecular Medicine|July 9, 2019
Mitochondrial MsrB2 serves as a switch and transducer for mitophagySeung Hee Lee, Suho Lee, Jing Du, et al.Plos Medicine|December 5, 2008
Ovarian carcinoma subtypes are different diseases: implications for biomarker studiesMartin Köbel, Steve E Kalloger, Niki Boyd, et al.European Journal of Cancer (Oxford, England : 1990)|April 25, 2013
A prospective clinical utility and pharmacoeconomic study of the impact of the 21-gene Recurrence Score® assay in oestrogen receptor positive node negative breast cancerJ A Davidson, I Cromwell, S L Ellard, et al.Cold Spring Harbor Molecular Case Studies|December 6, 2018
Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancerErica S Tsang, Yaoqing Shen, Negar Chooback, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|September 4, 2016
Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung CancerBrandon S Sheffield, Regan Fulton, Steve E Kalloger, et al.Current Oncology (Toronto, Ont.)|June 23, 2016
Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, J Agulnik, R Albadine, et al.Current Oncology (Toronto, Ont.)|November 23, 2018
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancerB Melosky, P Cheema, J Agulnik, et al.Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.Cancer Prevention Research (Philadelphia, Pa.)|September 24, 2016
A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial DysplasiaStephen Lam, Sumithra J Mandrekar, Yaron Gesthalter, et al.Chest|May 5, 2016
Low Prevalence of High-Grade Lesions Detected With Autofluorescence Bronchoscopy in the Setting of Lung Cancer Screening in the Pan-Canadian Lung Cancer Screening StudyAlain Tremblay, Niloofar Taghizadeh, Annette M McWilliams, et al.Pageof 12